Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.

Abstract

In an attempt to reduce or eliminate homologous red blood cell transfusion requirements during allogeneic bone marrow transplantation (BMT), we instituted a novel program whereby recombinant human erythropoietin was administered to pairs of BMT donors and recipients. Eleven recipients and their HLA-matched donors were enrolled. Donors treated with… (More)

Topics

6 Figures and Tables

Cite this paper

@article{Mitus1994UseOR, title={Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.}, author={A Jacqueline Mitus and J H Antin and Cynthia J Rutherford and Carol McGarigle and Mark Goldberg}, journal={Blood}, year={1994}, volume={83 7}, pages={1952-7} }